Baxter Net Long-Term Debt 2010-2025 | BAX

Baxter net long-term debt for the twelve months ending March 31, 2025 was $-7.433B, a 153.69% increase year-over-year.

  • Baxter annual net long-term debt for 2024 was $-2.657B, a 0.87% increase from 2023.
  • Baxter annual net long-term debt for 2023 was $-2.634B, a 176.1% increase from 2022.
  • Baxter annual net long-term debt for 2022 was $-0.954B, a 110.23% decline from 2021.

Baxter Net Long-Term Debt 2010-2025 | BAX

  • Baxter annual net long-term debt for 2024 was $-2.657B, a 0.87% increase from 2023.
  • Baxter annual net long-term debt for 2023 was $-2.634B, a 176.1% increase from 2022.
  • Baxter annual net long-term debt for 2022 was $-0.954B, a 110.23% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$232.4B
Boston Scientific (BSX)$153.7B
Stryker (SYK)$150.7B
EssilorLuxottica (ESLOY)$135.2B
Medtronic (MDT)$114.7B
Lonza Group Ag (LZAGY)$51.4B
Haleon (HLN)$45.4B
ResMed (RMD)$37.8B
Agilent Technologies (A)$35.3B
GE HealthCare Technologies (GEHC)$35B
Terumo (TRUMY)$24.7B
Koninklijke Philips (PHG)$23.7B
Insulet (PODD)$20.9B
Zimmer Biomet Holdings (ZBH)$18.8B
Smith & Nephew SNATS (SNN)$13.6B
Demant (WILYY)$9B
Sunny Optical Technology (SNPTF)$8.6B
Bio-Rad Laboratories (BIO)$7.1B
Lantheus Holdings (LNTH)$5.8B
Prestige Consumer Healthcare (PBH)$3.8B
Haemonetics (HAE)$3.8B
Perrigo (PRGO)$3.7B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
ICU Medical (ICUI)$3.4B
QuidelOrtho (QDEL)$2.1B
LeMaitre Vascular (LMAT)$1.9B
AtriCure (ATRC)$1.6B
Acuren (TIC)$1.4B
Green Thumb Industries (GTBIF)$1.4B